^
    BIOMARKER:

    CDKN2A mutation

    i
    Other names: CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf, Cyclin-dependent kinase inhibitor 2A




    Show legend

    Include preclinical:
    Squamous Cell Carcinoma of Head and Neck
    Breast Cancer
    Triple Negative Breast Cancer
    Non Small Cell Lung Cancer
    Clear Cell Renal Cell Carcinoma
    Penile Cancer
    Melanoma
    Gallbladder Cancer
    Pancreatic Cancer
    Solid Tumor
    Urothelial Cancer
    Biliary Tract Cancer
    ribociclib
    atezolizumab
    palbociclib
    nivolumab
    AZD1775 + VIC-1911
    toripalimab-tpzi
    Immunotherapy